Skip to main content
Livermore
Livermore
ZHEN

Artal Group S.A.

SEC CIK
0001053906
Latest filing
Aug 13, 2026

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by Artal Group S.A., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overviewAll 13F holders of LXRXFull Q2 2026 holdings

Shares (Q2 2026)
175,156,062
Value
$420.4M
% of portfolio
45.1%
Quarters held
22
Since Q1 2021
Holdings of LXRX by Artal Group S.A., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026175,156,062$420.4M45.1%+20,421,735+13.2%AddedHolders
Q1 2026154,734,327$241.4M23.9%+18,553,846+13.6%AddedHolders
Q4 2025136,180,481$156.6M21.9%00.0%UnchangedHolders
Q3 2025136,180,481$183.8M24.2%00.0%UnchangedHolders
Q2 2025136,180,481$129.4M13.9%00.0%UnchangedHolders
Q1 2025136,180,481$62.6M7.1%00.0%UnchangedHolders
Q4 2024136,180,481$100.8M8.6%00.0%UnchangedHolders
Q3 2024136,180,481$213.8M9.0%−38,918,903−22.2%ReducedHolders
Q2 2024175,099,384$294.2M7.6%+57,546,100+49.0%AddedHolders
Q1 2024117,553,284$282.1M7.3%00.0%UnchangedHolders
Q4 2023117,553,284$179.9M6.1%00.0%UnchangedHolders
Q3 2023117,553,284$128.1M5.6%00.0%UnchangedHolders
Q2 2023117,553,284$269.2M8.6%+27,775,050+30.9%AddedHolders
Q1 202389,778,234$218.2M13.0%00.0%UnchangedHolders
Q4 202289,778,234$171.5M9.9%00.0%UnchangedHolders
Q3 202289,778,234$215.5M11.2%+18,599,870+26.1%AddedHolders
Q2 202271,178,364$132.4M7.4%00.0%UnchangedHolders
Q1 202271,178,364$148.8M6.3%00.0%UnchangedHolders
Q4 202171,178,364$280.4M8.2%00.0%UnchangedHolders
Q3 202171,178,364$342.4M8.4%00.0%UnchangedHolders
Q2 202171,178,364$326.7M7.4%00.0%UnchangedHolders
Q1 202171,178,364$417.8M8.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.